Publisher
Springer Berlin Heidelberg
Reference14 articles.
1. Bickers DR, Frank J (2012) The porphyrias. In: Wolff K, Goldsmit LA, Katz SI et al (eds) Fitzpatrick’s dermatology in general medicine, 8th edn. McGraw-Hill, New York, pp 1538–1573
2. Biolcati G, Marchesini E, Sorge F et al (2015) Long-term observational study of afamelanotide in 115 patients with erythropoietic protoporphyria. Br J Dermatol 172:1601–1612
3. Fontanellas A, Ávila MA, Berraondo (2016) Emerging therapies for acute intermittent porphyria. Expert Rev Mol Med 18:e17. 1–13
4. Frank J, Poblete-Gutiérrez P (2010) Porphyria cutanea tarda – when skin meets liver. Best Pract Res Clin Gastroenterol 24:735–745
5. Gouya L, Puy H, Robreau AM et al (2002) The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH. Nat Genet 30:27–28